Join to view full profile
4921 Parkview Pl# DvSt. Louis, MO 63110
Phone+1 314-362-1408
Fax+1 314-286-1985
Dr. McDade is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Eric McDade is a neurologist in Saint Louis, MO and is affiliated with Barnes-Jewish Hospital. He received his medical degree from Chicago College of Osteopathic Medicine at Midwestern University and has been in practice 12 years. He specializes in neurodegenerative and dementia & geriatrics and is experienced in alzheimer's disease and aphasia. He has more than 100 publications and over 500 citings.
Education & Training
Mayo Clinic College of Medicine and ScienceFellowship, Behavioral neurology, 2008 - 2010
University of MarylandResidency, Neurology, 2005 - 2008
University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 2004 - 2005
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 2004
Certifications & Licensure
IL State License 2021 - 2029
MO State License 2016 - 2027
PA State License 2010 - 2016
MN State License 2008 - 2010
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2012-2015, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2015, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2015, 2017
Clinical Trials
Publications & Presentations
PubMed
- APOE and genetic risk variants influence Alzheimer's disease onset in carriers of an extra copy of APP, with and without Down syndrome.Joan Groeneveld, Danna Perlaza, Clàudia Olivé, Lou Grangeon, Niccolo Tesi
Alzheimer's & Dementia. 2026-08-01 - Biomarker Variability Limits Individualized Amyloid Time Estimation in Alzheimer Disease.Julie K Wisch, Ziqiao Jiao, Peter R Millar, Nicole S McKay, Aleksandra Beric
Biorxiv. 2026-07-13 - Statistical models for Alzheimer's disease clinical trials: Lessons learned from the DIAN-TU Platform Trial.Yan Li, Guoqiao Wang, Chengjie Xiong, Guogen Shan, Yuchen Cao
Journal of Alzheimer's Disease. 2026-06-01
Other
- Stop Alzheimer’s Before It StartsEric McDade, DO, Nature
https://www.doximity.com/articles/ec48e4b3-4116-4a55-ab3e-a95a0da3c80b
UpToDate, Wolters Kluwer Health - 2011-10-05 - Stop Alzheimer’s Before It StartsEric McDade, DO, Nature
https://www.doximity.com/articles/ec48e4b3-4116-4a55-ab3e-a95a0da3c80b
UpToDate, Wolters Kluwer Health - 2013-02-06
Press Mentions
Small Study Hints Anti-Amyloid Therapy May Keep Alzheimer’s Symptoms at Bay in Certain PatientsMarch 21st, 2025- Groundbreaking Alzheimer’s Prevention Trial Starts for Young AdultsFebruary 4th, 2025
- International Alzheimer’s Prevention Trial in Young Adults BeginsFebruary 4th, 2025
Grant Support
- DIAN-TU Primary Prevention TrialWASHINGTON UNIVERSITY2018–2031
- Multidisciplinary Training in Alzheimer and Related DementiasWASHINGTON UNIVERSITY2018–2029
- DIAN-TU Primary Prevention TrialWASHINGTON UNIVERSITY2018–2026
- DIAN-TU Primary Prevention TrialWASHINGTON UNIVERSITY2018–2026
- K23National Institution on Aging2015–2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
